Literature DB >> 23091084

Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010.

Qiuping Gu1, Vicki L Burt, Charles F Dillon, Sarah Yoon.   

Abstract

BACKGROUND: The monitoring of national trends in hypertension treatment and control can provide important insight into the effectiveness of primary prevention efforts for cardiovascular disease. The objective of this study was to examine recent trends in antihypertensive medication use and its impact on blood pressure control among US adults with hypertension. METHODS AND
RESULTS: A total of 9320 hypertensive people aged ≥18 years from the National Health and Nutrition Examination Survey 2001 to 2010 were included in this study. The prevalence of antihypertensive medication use increased from 63.5% in 2001 to 2002 to 77.3% in 2009 to 2010 (P(trend)<0.01). Most notably, there was a large increase in the use of multiple antihypertensive agents (from 36.8% to 47.7%, P(trend)<0.01). Overall, the use of thiazide diuretics, β-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers increased by 23%, 57%, 31%, and 100%, respectively. In comparison with monotherapy, single-pill combinations and multiple-pill combinations were associated with 55% and 26% increased likelihoods of blood pressure control, respectively. By the 2009 to 2010 time period, 47% of all hypertensive people and 60% of treated hypertensive people had blood pressure controlled. However, higher treated but uncontrolled hypertension rates continued to persist among older Americans, non-Hispanic blacks, diabetic people, and those with chronic kidney disease. Also, Mexican Americans with hypertension were still less likely to take antihypertensive medication than non-Hispanic whites with hypertension.
CONCLUSIONS: Antihypertensive medication use and blood pressure control among US adults with hypertension significantly increased over the past 10 years. Combination therapy regimens can facilitate achievement of blood pressure goals.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23091084     DOI: 10.1161/CIRCULATIONAHA.112.096156

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  209 in total

1.  The Difficulties in Antihypertensive Drug Prescription During Lactation: Is the Information Consistent?

Authors:  Sofia Colaceci; Angela Giusti; Elise Merrill Chapin; Micaela Notarangelo; Alessia De Angelis; Ercole Vellone; Rosaria Alvaro
Journal:  Breastfeed Med       Date:  2015-11-13       Impact factor: 1.817

Review 2.  Position statement on use of pharmacological combinations in a single pill for treatment of hypertension by Argentine Federation of Cardiology (FAC) and Argentine Society of Hypertension (SAHA).

Authors:  Nicolás Renna; Daniel Piskorz; Diego Stisman; Diego Martinez; Ludmila Lescano; Sergio Vissani; Walter Espeche; Diego Marquez; Roberto Parodi; Diego Naninni; Marcos Baroni; Daniel Llanos; Rocio Martinez; Jessica Barochinner; Gustavo Staffieri; Fernando Lanas; Mónica Velásquez; Marcos Marin; Bryan Williams; Irene Ennis
Journal:  J Hum Hypertens       Date:  2021-06-04       Impact factor: 3.012

3.  Optimal combination treatment and vascular outcomes in recent ischemic stroke patients by premorbid risk level.

Authors:  Jong-Ho Park; Bruce Ovbiagele
Journal:  J Neurol Sci       Date:  2015-05-28       Impact factor: 3.181

4.  Ecotoxicological evaluation of propranolol hydrochloride and losartan potassium to Lemna minor L. (1753) individually and in binary mixtures.

Authors:  Aline A Godoy; Fábio Kummrow; Paulo Augusto Z Pamplin
Journal:  Ecotoxicology       Date:  2015-04-07       Impact factor: 2.823

5.  Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults.

Authors:  Mary E Tinetti; Ling Han; David S H Lee; Gail J McAvay; Peter Peduzzi; Cary P Gross; Bingqing Zhou; Haiqun Lin
Journal:  JAMA Intern Med       Date:  2014-04       Impact factor: 21.873

Review 6.  Activation of mineralocorticoid receptor in salt-sensitive hypertension.

Authors:  Nobuhiro Ayuzawa; Toshiro Fujita
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

Review 7.  Psychosocial Stressors at Work and Ambulatory Blood Pressure.

Authors:  Xavier Trudel; Chantal Brisson; Mahée Gilbert-Ouimet; Alain Milot
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

8.  Targeting Pim Kinases and DAPK3 to Control Hypertension.

Authors:  David A Carlson; Miriam R Singer; Cindy Sutherland; Clara Redondo; Leila T Alexander; Philip F Hughes; Stefan Knapp; Susan B Gurley; Matthew A Sparks; Justin A MacDonald; Timothy A J Haystead
Journal:  Cell Chem Biol       Date:  2018-07-19       Impact factor: 8.116

Review 9.  Research Needs to Improve Hypertension Treatment and Control in African Americans.

Authors:  Paul K Whelton; Paula T Einhorn; Paul Muntner; Lawrence J Appel; William C Cushman; Ana V Diez Roux; Keith C Ferdinand; Mahboob Rahman; Herman A Taylor; Jamy Ard; Donna K Arnett; Barry L Carter; Barry R Davis; Barry I Freedman; Lisa A Cooper; Richard Cooper; Patrice Desvigne-Nickens; Nara Gavini; Alan S Go; David J Hyman; Paul L Kimmel; Karen L Margolis; Edgar R Miller; Katherine T Mills; George A Mensah; Ann M Navar; Gbenga Ogedegbe; Michael K Rakotz; George Thomas; Jonathan N Tobin; Jackson T Wright; Sung Sug Sarah Yoon; Jeffrey A Cutler
Journal:  Hypertension       Date:  2016-09-12       Impact factor: 10.190

10.  The Role of Care Management as a Population Health Intervention to Address Disparities and Control Hypertension: A Quasi-Experimental Observational Study.

Authors:  Tanvir Hussain; Whitney Franz; Emily Brown; Athena Kan; Mekam Okoye; Katherine Dietz; Kara Taylor; Kathryn A Carson; Jennifer Halbert; Arlene Dalcin; Cheryl A M Anderson; Romsai T Boonyasai; Michael Albert; Jill A Marsteller; Lisa A Cooper
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.